Published online Sep 26, 2015. doi: 10.4330/wjc.v7.i9.571
Peer-review started: April 3, 2015
First decision: April 28, 2015
Revised: July 30, 2015
Accepted: August 20, 2015
Article in press: August 21, 2015
Published online: September 26, 2015
Processing time: 170 Days and 9.9 Hours
Core tip: To establish the timing of discontinuation of double antiplatelet therapy before coronary artery bypass grafting (CABG), it is crucial to identify predictors of bleeding. We analysed preoperatively classic parameters and thromboelastometry on 100 patients operated for CABG after presenting with acute coronary syndrome, to investigate the contribution of anti-platelet therapy and derangements of pre-operative coagulation status to major bleeding post-CABG. We observed that patients with a low area-under-curve (AUC) value in EXTEM were at a significantly higher risk of bleeding compared to patients with higher AUC, regardless of anti-platelet treatment. This suggests that thrombin generation potential, irrespective of the degree of platelet inhibition, correlates with surgical bleeding.
